309 filings
Page 9 of 16
424B5
xaomyqs ymska
27 Apr 20
Prospectus supplement for primary offering
5:27pm
8-K
0lrwoc
25 Mar 20
Oncocyte Provides Corporate Update and Reports Fourth Quarter and Full Year 2019 Financial Results
5:06pm
8-K
y4m 8kzoj
20 Mar 20
Entry into a Material Definitive Agreement
4:30pm
424B5
kuiyr32
20 Mar 20
Prospectus supplement for primary offering
4:02pm
8-K/A
dx8skccqa58o23unzib
17 Mar 20
Index to Statement of Assets Acquired and Liabilities Assumed
5:28pm
8-K
b6b4i72 141ouc
6 Mar 20
Amendments to Articles of Incorporation or Bylaws
4:52pm
SEC STAFF
a7e19xa5sq83sj3o k1
19 Feb 20
SEC staff action: Order
12:00am
8-K
dgcg6w3 sq3lc7g7sv
14 Feb 20
Departure of Directors or Certain Officers
3:02pm
D
ryaj55gibbhz dx0wd03
11 Feb 20
$11M in equity, sold $5M, 29 investors
12:00am
SEC STAFF
titzmfpd26d
6 Feb 20
SEC staff action: Order
12:00am
8-K
sr6mn 3md3gspxvwk
5 Feb 20
Oncocyte Closes Merger Agreement to Acquire Insight Genetics
9:45am
8-K
89s 158fv
10 Jan 20
Oncocyte Announces Definitive Agreement to Acquire Insight Genetics
5:27pm
8-K
yil01
6 Jan 20
OncoCyte Announces $7.6 Million Registered Offering
5:29pm
424B5
rd94qe6kww 9vq
6 Jan 20
Prospectus supplement for primary offering
5:28pm
8-K
sszqtvgoqcb2 vo
27 Dec 19
Entry into a Material Definitive Agreement
5:16pm
8-K
7cu8 mxsd1r
14 Nov 19
Oncocyte Provides Corporate Update and Reports Third Quarter 2019 Financial Results
4:05pm
8-K
ae4yw8we0 dv
14 Nov 19
Entry into a Material Definitive Agreement
6:33am
424B5
cwu tg4el
14 Nov 19
Prospectus supplement for primary offering
6:32am